RARA and neoplasm: Among the DEGs, genes expressed at higher levels in RARα‐KO CTLs included major effector molecules required for anti‐tumor immunity, such as Ifng, Gzmb, and Prf1 (Figure 6A; Figure S9A, Supporting Information).